NCT06520072Completed
Mobile Apps for Preschool Parents (MAPP) Study
Source: ClinicalTrials.gov · Last updated 3 Jun 2026
Brief summary (registry, in English)
The purpose of Mobile Apps for Preschool Parents (MAPP) Study is to test the effectiveness of two mobile applications for parents of preschool aged children: 1) an app focused on child and family nutrition and wellness, and 2) an app focused on parents reading to their children.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 224 (actual)
- First submitted
- 22 Jul 2024
- Start date
- 1 Aug 2024
- Primary completion date
- 19 Nov 2024
- Lead sponsor
- Pamela Hull
- Diseases
- Obesity
- NCT number
- NCT06520072
What you commit to
- Study type: Interventional
- Participants enrolled: 224
- From 1 Aug 2024 to the primary completion date, 19 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Does not own iOS/Apple or Android mobile device (phone or tablet)
- Does not have internet access for the mobile device (data plan on device or in-home WiFi)
- Not able to successfully load and access the Intervention Arm or Attention Control Arm mobile app on the mobile device at the time of enrollment
Who the study is looking for
- Parent/Guardian (age 18+ years) of a 2-5 year old
- Living in United States
- Receives services at partner community organization (Organization Sample only)
Age in the registry: 18 years to 99 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Kentucky Coordinator of this site? Confirm its status | Lexington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.